Lansoprazole and Fluid intake reduced - a phase IV clinical study of FDA data

Summary:

Fluid intake reduced is reported as a side effect among people who take Lansoprazole (lansoprazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Folic Acid, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Fluid intake reduced when taking Lansoprazole. It is created by eHealthMe based on reports of 128,069 people who have side effects when taking Lansoprazole from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Fluid intake reduced?

Fluid intake reduced is found to be associated with 558 drugs and 624 conditions by eHealthMe. Check the latest studies of Fluid intake reduced.

On Jul, 16, 2026

128,069 people reported to have side effects when taking Lansoprazole.
Among them, 53 people (0.04%) have Fluid intake reduced.

Could Lansoprazole cause Fluid intake reduced?

Among these 53 people:

How long have people been on Lansoprazole when they have Fluid intake reduced? *

What is the gender of people who have Fluid intake reduced when taking Lansoprazole? *

female: 64 %
male: 36 %

What is the age of people who have Fluid intake reduced when taking Lansoprazole? *

What are other drugs people take besides Lansoprazole? *

What are other side effects people have besides Fluid intake reduced? *

Fatigue (feeling of tiredness): 28 people, 52.83%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 25 people, 47.17%
Nausea (feeling of having an urge to vomit): 18 people, 33.96%
Dehydration (dryness resulting from the removal of water): 14 people, 26.42%
Weakness: 14 people, 26.42%
Anaemia (lack of blood): 14 people, 26.42%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 22.64%
Aspartate Aminotransferase Increased: 10 people, 18.87%
Weight Decreased: 10 people, 18.87%
Hypophagia (reduced food intake): 10 people, 18.87%

What are the existing conditions these people have? *

Dementia (madness): 6 people, 11.32%
Lung Cancer - Non-Small Cell (lung cancer): 6 people, 11.32%
Oral Candidiasis (fungal infection of mouth): 4 people, 7.55%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 4 people, 7.55%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 7.55%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 3.77%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 3.77%
Escherichia Bacteraemia (presence of bacteria escherichia coli in the blood): 2 people, 3.77%
Tumor: 2 people, 3.77%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and have Fluid intake reduced?

- Check whether Fluid intake reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lansoprazole:

Lansoprazole (129,663 reports)

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid intake reduced:

Fluid intake reduced (558 drugs)

Browse all the conditions that are associated with Fluid intake reduced:

Fluid intake reduced (624 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Lansoprazole) and Lansoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.